MedTrace Logo

Induction Related BK Viremia in Renal Transplant Patients

NCT00610961 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2011-09-27

No results posted yet for this study

Summary

The increase immunosuppression in our transplant population has led to an unacceptable rate of patients at risk for BK virus nephropathy. Reducing induction immunosuppression by switching from Thymoglobulin to Simulect will reduce the incidence of serum positivity for BK by PCR.

Conditions

  • Disease Due to BK Polyomavirus
  • Transplantation Infection
  • Disorder Related to Transplantation

Sponsors & Collaborators

Principal Investigators

  • Herwig-Ulf Meier-Kriesche, MD · University of Florida

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2009-04-30
Completion
2009-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00610961 on ClinicalTrials.gov